The ageing population is a global phenomenon. According to the UN’s “World Population Prospects 2019” by 2100, the world’s population is projected to reach approximately 10.9 billion. Moreover, bet...
The startup focuses on glioblastoma tumors with CAR-T therapy. CAR-T technology that involves genetically modifying a patient’s immune cells to recognize and attack cancer. However, while the innovation has helped patients with certain blood malignancies, progress in solid tumors remains restricted. The scien...
Find MoreCanSino adds mRNA with Precision NanoSystems CanSino Biologics is already evaluating a recombinant coronavirus vaccine in China. However, it is adding the mRNA to COVID-19 vaccine through a licensing agreement with Precision NanoSystems. The partners will work on an mRNA nanoparticle vaccine for COVID-1...
Find MoreSeveral promising new developments and novel treatment approaches are fuelling Huntington’s disease Market. Progressive neurological disorders such as Parkinson disease (PD), motor neuron disease (MND), Huntington disease (HD), or multiple sclerosis (MS), despite the advent of technological advances in healthc...
Find MoreFlorence-based Menarini Group has announced a USD667 million acquisition of the Stemline Therapeutics, an oncology-focused company. As per the agreement, Menarini plans to help Stemline to build a strong foothold in the U.S., and will also continue the development of Elzonris, a CD123 targeted therapy. Th...
Find MoreRemdesivir of Gilead accelerates COVID-19 recovery Gilead Sciences' Remdesivir shows the first data from a placebo-controlled study. Remdesivir decreases recovery time for hospitalized COVID-19 patients by four days or 31% as published in a National Institutes of Health-sponsored study setting the drug against p...
Find MoreAbbVie, Sofinnova back USD 38 Million for Nitrome Biosciences Nitrome Biosciences contemplates treating Parkinson's disease and diabetes by targeting a new class of enzymes. The pharma raised USD 38 million from the Sofinnova Partners and AbbVie Ventures. The San Francisco-based biotech is focusing at a famil...
Find MoreSage Therapeutics seeking out to save flunked depression drug Sage Therapeutics has strategized on how to come back from the phase 3 failure of SAGE-217 in major depressive disorder. The plan focuses on three short-term studies Sage contemplates that may enable it to bring the GABA receptor positive allost...
Find MoreThe dream of the UAE government to place its capital city among the best cities in the world has led to the introduction of ‘Dubai plan 2021’, focused on transforming into a smart city through an investment of more than USD 7 Billion. Dubai’s smart city strategy includes over 100 initiatives, which aims at fosterin...
Find MoreCocaine- a stimulant- made from the most addictive plant - cocoa plant, is known as the most addictive substance known to be existing on the Earth, hence is abused the most. As per the annual report titled ‘Key Substance Use and Mental Health Indicators in the United States’ presented by the National Survey on Drug...
Find MoreMyasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skel.....
Find MoreGastroesophageal Reflux Disease (GERD, also known as chronic acid reflux) is a digestive disorder in.....
Find MoreGene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....
Find MoreT cell Lymphoma (TCL) is cancer that develops in the T-lymphocytes. T-cell Lymphomas are majorly cla.....
Find MoreThere are about 200 different types of cancer, making it one of the most diverse types of indication.....
Find MoreAn autosomal recessive disorder, Ataxia Telangiectasia, affects a person's nervous system, immune sy.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.